Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 8
2011 6
2013 4
2014 2
2015 6
2016 4
2017 1
2018 4
2019 9
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Oxadiazole scaffolds in anti-tuberculosis drug discovery.
De SS, Khambete MP, Degani MS. De SS, et al. Among authors: degani ms. Bioorg Med Chem Lett. 2019 Aug 15;29(16):1999-2007. doi: 10.1016/j.bmcl.2019.06.054. Epub 2019 Jun 28. Bioorg Med Chem Lett. 2019. PMID: 31296357 Review.
Repositioning of DHFR Inhibitors.
Lele AC, Mishra DA, Kamil TK, Bhakta S, Degani MS. Lele AC, et al. Among authors: degani ms. Curr Top Med Chem. 2016;16(19):2125-43. doi: 10.2174/1568026616666160216152540. Curr Top Med Chem. 2016. PMID: 26881719 Review.
Synthesis and mycobacterial evaluation of 5-substituted-6-acetyl-2-amino-7-methyl-5,8-dihydropyrido-[2,3-d]pyrimidin-4(3H)-one derivatives.
Agre N, Degani M, Gupta A, Bhakta S, Ray MK. Agre N, et al. Among authors: degani m. Arch Pharm (Weinheim). 2019 Sep;352(9):e1900068. doi: 10.1002/ardp.201900068. Epub 2019 Jul 24. Arch Pharm (Weinheim). 2019. PMID: 31339194
Rational design of coumarin derivatives as antituberculosis agents.
Mali HM, Sabale SS, Degani MS, Borkute R, Choudhari AS, Sarkar D, Krishna VS, Sriram D. Mali HM, et al. Among authors: degani ms. Future Med Chem. 2018 Oct;10(20):2431-2444. doi: 10.4155/fmc-2018-0015. Epub 2018 Oct 16. Future Med Chem. 2018. PMID: 30325198
Design and synthesis of 5-(5-nitrothiophen-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazole derivatives with improved solubility and potential antituberculosis activity.
Khambete M, Kundaikar H, Raju A, Lonkar S, Degani M, Ray MK. Khambete M, et al. Among authors: degani m. Chem Biol Drug Des. 2019 Jan;93(1):84-88. doi: 10.1111/cbdd.13386. Epub 2018 Oct 8. Chem Biol Drug Des. 2019. PMID: 30142699
Synthesis and in-vivo taste assessment of meloxicam pivalate.
Chatale BC, Degani MS. Chatale BC, et al. Among authors: degani ms. Drug Dev Ind Pharm. 2019 Oct;45(10):1590-1598. doi: 10.1080/03639045.2019.1628250. Epub 2019 Jul 15. Drug Dev Ind Pharm. 2019. PMID: 31306048
Homology modelling of human divalent metal transporter (DMT): Molecular docking and dynamic simulations for duodenal iron transport.
Anantram A, Janve M, Degani M, Singhal R, Kundaikar H. Anantram A, et al. Among authors: degani m. J Mol Graph Model. 2018 Oct;85:145-152. doi: 10.1016/j.jmgm.2018.08.006. Epub 2018 Aug 16. J Mol Graph Model. 2018. PMID: 30193229
Exploration of 5-(5-nitrothiophen-2-yl)-4,5-dihydro-1H-pyrazoles as selective, multitargeted antimycobacterial agents.
Agre N, Khambete M, Maitra A, Gupta A, Munshi T, Bhakta S, Degani M. Agre N, et al. Among authors: degani m. Chem Biol Drug Des. 2020 Jan;95(1):192-199. doi: 10.1111/cbdd.13624. Epub 2019 Oct 14. Chem Biol Drug Des. 2020. PMID: 31560814
Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
Anantram A, Kundaikar H, Degani M, Prabhu A. Anantram A, et al. Among authors: degani m. J Biomol Struct Dyn. 2019 Aug;37(12):3109-3121. doi: 10.1080/07391102.2018.1508371. Epub 2018 Dec 10. J Biomol Struct Dyn. 2019. PMID: 30526410
43 results
Jump to page
Feedback